GBA1 and Parkinson disease: The integrated experimental data was previously acquired from midbrain organoids generated from induced pluripotent stem cells (iPSCs) of PD patients harbouring LRRK2-G2019S31,32, SNCA triplication33, GBA-N370S34 or MIRO1-R272Q35 mutations.